Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

Tranilast: An angiotensin II antagonist

June 7, 1996

First chronotherapeutic agent for hypertension and angina now avaliable in U.S.

June 7, 1996

Elan acquires rights to diazepam gel formulation

June 7, 1996

Transdermal buspirone covered under U.S. patent

June 7, 1996

InSite Vision and Ciba Vision marketing agreement for sustained-release eyedrop formulation

June 7, 1996

Development of AccuSite for basal cell carcinoma delayed

June 7, 1996

Controlled-release naproxen sodium now on U.S. shelves

June 7, 1996

Anika Research seeks European marketing approval for Orthovisc

June 7, 1996

Fluorouracil/epinephrine injectable gel approved

June 7, 1996

Favorable trial results with interferon gamma-1b for atopic dermatitis and keloids

June 7, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Molecular signatures show subtypes in neurodegenerative diseases
BioWorld Science
Parkinson’s disease is a progressive neurodegenerative disorder best known for its motor symptoms. However, a proportion of patients also develop dementia as the...